On January 1, 2016, the appointment of Frank Luppino as Anika Therapeutics Inc.'s Chief Operating Officer has ended, as planned. Moving forward, Mr. Luppino will continue to serve as a consultant to Anika Therapeutics Inc. on an as-needed basis.